Protocols
1 protocol(s) meet the specified criteria
Drug: Nivolumab
Protocol No.TitleStatus
CA209-274A Phase 3 Randomized, Double-blind, Multi-center Study of Adjuvant Nivolumab versus Placebo in Subjects with High Risk Invasive Urothelial CarcinomaOpen